Reveal HealthTech, a healthcare-focused artificial intelligence startup, has raised $7.2 million in a Series A funding round led by Leo Capital, with participation from Sanos Capital. The funding marks a significant milestone for the company as it seeks to expand its AI-driven healthcare solutions and strengthen its position as a specialized technology partner for healthcare and life sciences organizations.

The company, which was founded in 2023 and incubated by W Health Ventures and 2070 Health, has focused on helping healthcare organizations adopt artificial intelligence safely and effectively. The latest financing brings Reveal HealthTech’s total disclosed funding to approximately $11.2 million, following a $4 million seed round raised from W Health Ventures in 2023.

Headquartered in the United States with significant operations in India, Reveal HealthTech works with healthcare providers, pharmaceutical companies, and digital health organizations to build and deploy AI-powered systems. The company combines engineering expertise, clinical knowledge, and strategic guidance to help organizations integrate artificial intelligence into healthcare workflows while maintaining safety, compliance, and clinical relevance.

According to the company, the new capital will be used to scale its flagship products and accelerate growth across the healthcare sector. Among its key offerings is BioCanvas, a platform that applies multimodal artificial intelligence to improve clinical trial recruitment and patient matching. The company also offers Prism AI, a workflow automation platform designed to streamline operational processes across healthcare organizations.

The healthcare industry has increasingly turned to artificial intelligence to address workforce shortages, improve patient outcomes, reduce administrative burdens, and accelerate research. However, healthcare organizations often face challenges implementing AI technologies because of regulatory requirements, data privacy concerns, and the need for clinically validated solutions. Reveal HealthTech aims to bridge that gap by combining healthcare expertise with advanced technology development.

The participation of Leo Capital and Sanos Capital reflects growing investor interest in healthcare AI companies that focus on practical deployment rather than purely experimental technologies. Leo Capital is known for backing early-stage technology companies across sectors including enterprise software, artificial intelligence, and digital transformation. Sanos Capital, meanwhile, invests in businesses that seek to improve healthcare delivery and patient outcomes through innovation.

The Series A financing also represents continued confidence from the company’s existing supporters. Reveal HealthTech emerged from the venture-building ecosystem created by W Health Ventures and 2070 Health, organizations that focus on launching and scaling healthcare companies addressing critical gaps in care delivery. Their ongoing involvement highlights the company’s progress since its founding and its ability to attract institutional investment as it expands.

Since its launch, Reveal HealthTech has positioned itself as an AI transformation partner rather than a conventional software vendor. The company works closely with healthcare organizations to identify operational and clinical challenges before designing technology solutions tailored to specific use cases. This approach has enabled Reveal HealthTech to establish relationships across multiple segments of the healthcare industry, including provider networks, life sciences organizations, and digital health companies.

The broader healthcare AI market has experienced rapid growth over the past several years as advances in machine learning, natural language processing, and automation create new opportunities to improve efficiency and patient care. Investors have increasingly targeted companies capable of delivering measurable outcomes while navigating the complex regulatory and operational requirements of healthcare systems.

With fresh funding in place, Reveal HealthTech plans to continue investing in product development, customer acquisition, and expansion efforts. The company believes artificial intelligence can play a meaningful role in improving healthcare delivery when implemented responsibly and supported by clinical expertise.

As healthcare organizations seek scalable solutions to growing operational pressures, Reveal HealthTech is positioning itself at the intersection of technology innovation and healthcare transformation. Backed by Leo Capital, Sanos Capital, W Health Ventures, and 2070 Health, the company now has additional resources to accelerate its growth and expand the reach of its AI-powered healthcare platforms.

Related Articles